1-5 of 5
pravastatin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

Swapnil N. Rajpathak, MD, DRPH, Dharam J. Kumbhani, MD, SM, Jill Crandall, MD, Nir Barzilai, MD, Michael Alderman, MD, Paul M. Ridker, MD
Journal: Diabetes Care
Diabetes Care 2009;32(10):1924–1929
https://doi.org/10.2337/dc09-0738
Published: 01 October 2009
View article titled, Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Open the PDF for Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis in another window
Journal Articles

Anti-Inflammatory and Anticoagulant Effects of Pravastatin in Patients With Type 2 Diabetes

Dirkje W. Sommeijer, MD, Melvin R. MacGillavry, MD, PHD, Joost C.M. Meijers, PHD, Anton P. Van Zanten, PHD, Pieter H. Reitsma, PHD, Hugo Ten Cate, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(2):468–473
https://doi.org/10.2337/diacare.27.2.468
Published: 01 February 2004
View article titled, Anti-Inflammatory and Anticoagulant Effects of Pravastatin in Patients With Type 2 Diabetes
Open the PDF for Anti-Inflammatory and Anticoagulant Effects of Pravastatin in Patients With Type 2 Diabetes in another window
Journal Articles

Validation of the Archimedes Diabetes Model

David M. Eddy, MD, PHD, Leonard Schlessinger, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3102–3110
https://doi.org/10.2337/diacare.26.11.3102
Published: 01 November 2003
View article titled, Validation of the Archimedes Diabetes Model
Open the PDF for Validation of the Archimedes Diabetes Model in another window
Journal Articles

Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: Results from the LIPID trial

Anthony Keech, MBBS, FRACP, David Colquhoun, MBBS, FRACP, James Best, MD, FRACP, Adrienne Kirby, MSC, R. John Simes, MD, FRACP, David Hunt, MD, FRACP, Wendy Hague, MBBS, MBA, Elaine Beller, MAPPSTAT, Manjula Arulchelvam, MSC, Jennifer Baker, MBBS, MSC, Andrew Tonkin, MD, FRACP, for the LIPID Study Group
Journal: Diabetes Care
Diabetes Care 2003;26(10):2713–2721
https://doi.org/10.2337/diacare.26.10.2713
Published: 01 October 2003
View article titled, Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: <subtitle>Results from the LIPID trial </subtitle>
Open the PDF for Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: <subtitle>Results from the LIPID trial </subtitle> in another window
Journal Articles

Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients

Tadasu Ikeda, MD
Journal: Diabetes Care
Diabetes Care 1993;16(5):849–850
https://doi.org/10.2337/diacare.16.5.849
Published: 01 May 1993
View article titled, Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients
Open the PDF for Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients in another window